Wednesday , May 22 2019
Home / chile / The meningitis vaccine B shares public health

The meningitis vaccine B shares public health

Vaccine against meningitis B shared by Spanish public health. Autonomous Communities like The Canary Islands and Castilla y León they have already decided to fund public money while Andalusia it intends to "incorporate it, if possible, by 2020 or 2021," as announced by Health and Family Adviser, Jesús Aguirre. However, other regions, such as the Ministry of Health, have excluded this public funding vaccine, which for private individuals may presume cost about 400 euros and is administered in three doses in the first twelve months of newborns.

Public Health CommissionThe ministry and health departments of various autonomous communities meet, gave green light last Thursday generalization tetravalent vaccine which protects 12-year-olds from types A, C, W and Y. But B is left out, which has babies as one of the main targets.

As the ministry justifies, the attitude towards general vaccination against meningitis B has been taken into account. " epidemiological situation currently, together with available vaccine information, which shows a short duration of protection after vaccination, lack of protection against untreated populations, lack of efficacy data, and high reactivity when applied together with childhood calendar vaccines. "

Version of those affected

Considering the technical criteria that have been made by most of the Public Health Commission, there are groups of affected and pediatric patients. Spanish Association Against Meningitis he thinks that progress has been achieved with tetravalent positive, but then he asks: "What will we tell parents who have lost their baby due to meningitis B in the coming months …?"

From Spanish Pediatric Association (AEP) is also welcomed with publicly funded tetravalent but at the same time remembers a special "virulence and mortality" of all meningitis in the early years of life, including type B. The doctor Federico Martinón-Torres, The pediatrician at Santiago de Compostela University Clinical Hospital, "the Spanish meningococcal vaccine policy is insufficient" and adds, "Better Than Forgive".

Critics blame the Ministry of Health's decision for the causes of funding. In fact, AEP recommends vaccination against meningococcal B of 3 months.


Meningitis B is a disease that is caused by Spain 300 infections per yearof which approximately 10% are deadly, and the other 20% result in serious physical consequences, including amputation of the leg or hand, blindness or deafness. This is very weak fire, but serious consequences, especially in babies. If the price of the vaccine reaches 400 euros for individuals, as the Spanish Association against Meningitis has pointed out, the risk of meningitis B being caused by factors social inequality, affecting the poorest areas.

More information

Source link